NS

Nitu Sinha

Active Director Director DIN 03546484
DIN 03546484 First appointment Oct 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2011
Shareholding value •••• Premium profile

About Nitu Sinha

Data last updated:

Nitu Sinha is a Director at Tasha Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Tasha Pharmaceuticals Private Limited reported revenue of ₹2.1 Lakh (FY 2021).

DIN 03546484
Primary Designation Director
Industry Pharma
First Appointment 11 Oct 2011
Oldest Company Age 15 yrs
Largest company Tasha Pharmaceuticals Private Limited · ₹2.1 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Oct 20112011₹2.1 Lakh (FY 2021)Active

Board colleagues of Nitu Sinha

NameDINCompanyDesignation
Muni Shankar Prasad03546483Tasha Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Tasha Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nitu Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitu Sinha

Nitu Sinha currently holds 1 directorship: Tasha Pharmaceuticals Private Limited (Director, since 11 Oct 2011, revenue ₹2.1 Lakh (FY 2021)).

Nitu Sinha was first appointed on 11 Oct 2011 as Director at Tasha Pharmaceuticals Private Limited.

The current boards of Nitu Sinha's companies include Muni Shankar Prasad (Tasha Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available